AI & Tooling

Dr. Hannah Pederson discusses causes and treatments for stubborn rashes that do not resolve, highlighting important advice for affected patients.

• Gold IRA Markets Team
• July 7, 2026

LONGWELL’s biomimetic EC-Lüfter reaches a static efficiency of 73-82%, with notable noise reduction, marking a significant advancement in ventilation technology.

• Gold IRA Markets Team
• July 6, 2026

Hyundai Motor introduces the Atlas humanoid robot at the FIFA World Cup 2026 in its first live match environment, marking a major robotics milestone.

• Gold IRA Markets Team
• July 6, 2026

OpenAI proposes a 5% equity stake to the Trump administration amid reports of mounting regulatory and political pressure, aiming to secure favorable treatment.

• Gold IRA Markets Team
• July 3, 2026

OpenAI is reportedly negotiating to give the Trump administration a 5% equity stake, according to the Financial Times. Details remain uncertain.

• Gold IRA Markets Team
• July 3, 2026

iQIYI announces the return of ‘The King of Stand-Up Comedy’ for its third season, aiming to strengthen China’s comedy ecosystem and showcase top talent.

• Gold IRA Markets Team
• July 3, 2026

The President of the Public Affairs Council issued a birthday letter emphasizing the importance of civic engagement and community involvement.

• Gold IRA Markets Team
• July 3, 2026

Partner Therapeutics announced the publication of eNRGy trial results of Zenocutuzumab in NRG1+ cholangiocarcinoma in the Journal of Clinical Oncology.

• Gold IRA Markets Team
• July 2, 2026

A Ramp study shows that firms spending the most on AI are also growing their employment, highlighting a link between AI investment and job creation.

• Gold IRA Markets Team
• July 1, 2026

A Ramp study reveals companies investing heavily in AI are also expanding their workforce, highlighting the link between AI spending and job growth.

• Gold IRA Markets Team
• July 1, 2026